SS
TNGX icon

SBI Securities’s Tango Therapeutics TNGX Stock Holding History

SBI Securities’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344 Buy
11
+10
+1,000% +$247 ﹤0.01% 3160
2026
Q1 		$21 Sell
1
-18
-95% -$251 ﹤0.01% 3759
2025
Q4 		$168 Sell
19
-35
-65% -$302 ﹤0.01% 3266
2025
Q3 		$454 Buy
54
+43
+391% +$291 ﹤0.01% 3010
2025
Q2 		$56 Sell
11
-30
-73% -$74 ﹤0.01% 3694
2025
Q1 		$56 Buy
41
+30
+273% +$74 ﹤0.01% 3618
2024
Q4 		$34 Buy
+11
New +$51 ﹤0.01% 3718

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

SBI Securities's TNGX Position: Q2 2026 in Review

SBI Securities increased its Tango Therapeutics (TNGX) stake by 1,000% in Q2 2026, buying an estimated $247 and bringing the position to 11 shares worth $344. The position accounts for ﹤0.01% of the portfolio, ranked #3160.

SBI Securities first reported a position in TNGX in Q4 2024 and has held it in 7 quarters since. The position peaked at $454 in Q3 2025. 247 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • SBI Securities held 11 shares of Tango Therapeutics worth $344 as of Q2 2026.
  • SBI Securities bought 10 Tango Therapeutics shares in Q2 2026, an estimated $247.
  • Tango Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3160 holding.
  • SBI Securities first reported a position in Tango Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Tango Therapeutics position peaked at $454 in Q3 2025.
  • 247 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.